Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for Response

• Status: Completed
• Trial end date: 2007-05-01
• Target enrollment: 0
• Participant gender: All

Summary

To characterize the burden of disease in GERD patients of prescription therapy'

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Treatments: Esomeprazole

Criteria

Inclusion Criteria:

• Signed informed consent, 18 years or older, diagnosis of GERD

Exclusion Criteria:

• Peptic ulcer disease, upper gastrointestinal surgery, malignancy